IMRX

NASDAQStock

Immuneering Corporation

$5.03-0.42 (-7.80%)

52-Week Range

$1.10
$9.26

Key Stats

Market Cap

182.4M

P/E Ratio

Dividend Yield

Beta

0.45

Volume

1.3M

Avg Volume

751.0K

Performance

1M

+9.88%

3M

-5.71%

6M

-30.66%

YTD

-17.67%

1Y

+240.63%

3Y

-30.84%

5Y

-69.02%

Price Chart

ETF Exposure

IMRX is held by 26 ETFs

ETFFund NameWeight
CURE.AXGlobal X - S&P Biotech ETF0.16%
XBIState Street SPDR S&P Biotech ETF0.15%
IWCiShares Micro-Cap ETF0.06%
LABUDirexion Daily S&P Biotech Bull 3X ETF0.03%
IBBQInvesco Nasdaq Biotechnology ETF0.03%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.03%
PWSPacer WealthShield ETF0.03%
IBBiShares Biotechnology ETF0.02%
BIBProShares - Ultra Nasdaq Biotechnology0.02%
AVSCAvantis U.S. Small Cap Equity ETF0.01%
VXFVanguard Extended Market ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About IMRX ETF Exposure

Immuneering Corporation (IMRX) is held by 26 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 182.4M, IMRX is a widely held institutional stock. The stock currently trades at $5.03. Investors can gain exposure to IMRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IMRX, sorted by portfolio weight.